Share

The key list

Powered by

Leading mid-size pharma companies in Europe by revenue

This month our power industry key list brings you the 15 largest mid-size pharma companies in Europe by revenue, as ranked by GlobalData's Power Intelligence Centre. All numbers as of May 2020.

Company nameAnnual revenue ($million)Headquarters locationNumber of employees

Merck KGaA

17,508Germany57,071

UCB SA

5,466Belgium7,606

Grifols SA

5,295Spain24,003

Bayer AG

2,869Denmark5,569

AstraZeneca Plc

2,771
France5,723

GlaxoSmithKline Plc

2,750Germany10,232

Merck KGaA

2,076UK8,578

Allergan Plc

1,596Italy4,142

Novo Nordisk AS

1,154Finland3,265

UCB SA

1,094Ireland2,235

Mylan NV

1,005UK1,024

ALK-Abello AS

462Denmark2,384

Amarin Corp Plc

229Ireland964

BeiGene Ltd

198China3,000

Avadel Pharmaceuticals Plc

103Ireland144

Share this article

Go to article: Home | A cure for a costGo to article: In this issueGo to article: SHL Group Company InsightGo to article: Scandinavian HealthGo to article: ContentsGo to article: NewsGo to article: NSFGo to article: VEGA Company Insight Go to article: VEGA AustraliaGo to article: Covid-19 executive briefing by GlobalDataGo to article: The value of real-world evidence during the Covid-19 outbreakGo to article: Covid-19: UK restricts parallel export of nearly 200 drugs, threatening its biopharma industryGo to article: Pharmaceutical professionals say employee safety and supply chain disruption are top Covid-19 concernsGo to article: AbbVie’s, Ascletis’ protease inhibitors spark skeptical outlook for repurposed activity in Covid-19Go to article: PhoenixGo to article: Phoenix Company InsightGo to article: The pharma industry briefingGo to article: No time to waste: repurposing drugs to tackle covid-19Go to article: How safe are simple painkillers?Go to article: Molnar Company Insight Go to article: Molnar-InstituteGo to article: Modelling the human body: a game changer for drug testing?Go to article: Pandemic pricing: existing drugs and price gougingGo to article: Contract Pharmaceuticals Limited CanadaGo to article: Pandemic pricing: novel treatments and vaccinesGo to article: The dark side of anticoagulants: will a new approach shed light?Go to article: Zenatek Go to article: Finding a cure for HIV with ViiV Healthcare and UNC-Chapel HillGo to article: Disputing the facts: is the legal battle between Veeva and IQVIA an antitrust issueGo to article: Nelson LabsGo to article: Could nanoparticles unlock the pharmaceutical benefits of turmeric?Go to article: Why aren’t more companies automating PV data capture?Go to article: Modality SolutionsGo to article: Deals in brief powered by GlobalDataGo to article: The key list powered by GlobalDataGo to article: ButterworthGo to article: Global markets and indices powered by GlobalDataGo to article: Macro-economic indicators (1 of 2) powered by GlobalDataGo to article: Macro-economic indicators (2 of 2) powered by GlobalDataGo to article: MimotopesGo to article: EventsGo to article: Next issue